絞り込み

16639

広告

「"Shukla A "[Author]」の検索結果

955件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Hydrophobicity and oligomerization are essential parameters for membrane penetration activity of the VP4 peptide from Hepatitis A Virus (HAV).

Vulvovaginitis Caused by Candida Species Following Antibiotic Exposure.

Bain type of X-linked syndromic mental retardation in a male with a pathogenic variant in HNRNPH2.

The Effect of a Rapid Assessment Zone on Emergency Department Operations and Throughput.

Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.

Breast cancer survivorship care plans: what are they covering and how well do they align with national guidelines?

Direct Observation of Band Gap Renormalization in Layered Indium Selenide.

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles.

Hearing Loss, Hearing Aid Use and Depressive Symptoms in Older Adults - Findings from the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS).

Author Correction: A Genetic Screen for Investigating the Human Lysosomal CystineTransporter, Cystinosin.

Polyalthia longifolia leaves methanolic extract targets entry and budding of viruses-an in vitro experimental study against paramyxoviruses.

Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Systemic vasoprotection by inhaled carbon monoxide is mediated through prolonged alterations in monocyte/macrophage function.

Homozygous variant, p.(Arg643Trp) in VAC14 causes striatonigral degeneration: report of a novel variant and review of VAC14-related disorders.

Crossover to strange metal phase: quantum criticality in one unit cell Bi2Sr2CaCu2O8+x.

Mitochondrial cytochrome oxidase C subunit III (cox3) gene as a sensitive and specific target for molecular detection of Babesia gibsoni infection in dogs.

Association between patient-reported outcomes and objective disease indices in people with NF2.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります